Drug Combination in Clinical Cancer Treatments

E-ISSN： 1876-1038|12|3|202-211

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.12, Iss.3, 2017-11, pp. : 202-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New treatments for gastric cancer: are they changing clinical practice?

By Penna Marta Allum William

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 649-659

Future Medicine

Access to resources Recommend Favorite

New drug combination improves breast cancer outcomes

Women's Health, Vol. 2, Iss. 6, 2006-11 ,pp. : 801-804

Future Medicine

Access to resources Recommend Favorite

CLINICAL STUDY WITH A NEW HYDROCHOLERETIC DRUG AND A NEW HYDROCHOLERETIC‐ANTISPASMODIC COMBINATION

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 7, Iss. 3, 1959-03 ,pp. : 265-267

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Lasting Control of Triple-Negative Metastatic Breast Cancer with the Novel Drug Combination Ixabepilone and Capecitabine – Case Report

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 53-56

Karger

Access to resources Recommend Favorite

Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling Studies

Oncology, Vol. 72, Iss. 1-2, 2007-11 ,pp. : 118-124

Karger

Access to resources Recommend Favorite